Skip to content

Author

Liudmila Kulakova

We have 2 of 13 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Incorporation of native HCV E1E2 into a nanoparticle vaccine platform

These studies show that a well-characterized sE1E2 platform compatible with multiple genotypes can be coupled to nanoparticles for use as a vaccine candidate and sets the stage for further exploration of nanoparticles and other multivalent platforms for the development of E1E2-based vaccines.

Liudmila Kulakova, Sarah Jeong, Dong-Xiu Zhang et al. · 0 citations
Open access Jul 2026

Induction of Robust Immunity Against Hepatitis C Virus Using Rationally Adjuvanted Microneedle Patches Integrating A Secreted Form of E1E2 Heterodimer 2259568

The preclinical development of a novel HCV vaccine candidate engineered by formulating a novel native-like secreted E1E2 immunogen and a well-established combinatorial adjuvant of QS-21 + 3D-(6-acyl) PHAD into unique microneedle patches (MNPs).

Yi-Nuo Zhang, A. Dhayani, Stephen C. Balmert et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.